G-CURE aims to become a global scientific leader in the development of new (pharmacological) treatments for cardiovascular diseases with a focus on heart failure, preservation of left ventricular function after acute myocardial infarction and atrial fibrillation. We offer our unique skill sets and combined expertise to pharmaceutical, biotech and related industries, with services ranging from experimental animal studies to the creation of marketing authorisation dossiers.
Originating from the Department of Cardiology at the University Medical Center Groningen, G-CURE has a long-standing history of high quality scientific output in international cardiovascular research.
Overall focus area is the preservation of left ventricular function, with special interest in heart failure, atrial fibrillation and ischemic heart disease.
